Once known primarily for treating depression, interventional psychiatry is now being used to treat patients with a wide range of complex mental health conditions.
Interventional psychiatry is a branch of psychiatry that uses treatments outside of medication and therapy. As the field of interventional psychiatry advances, these innovative solutions are opening new doors for patients wanting to improve their mental health and well-being.
What is interventional psychiatry?
Interventional psychiatry is a specialized area of mental health care that uses advanced, evidence-based treatments like transcranial magnetic stimulation (TMS) and Spravato® (esketamine) to directly target brain activity. It is typically used when traditional approaches like medication and therapy alone have not been effective in relieving symptoms of depression and suicidal thoughts.
Interventional psychiatry differs in several ways from conventional psychiatry:
Treatment Approach
- Conventional psychiatry: Relies on medications and talk therapy
- Interventional psychiatry: Uses advanced treatments like TMS, electroconvulsive therapy (ECT), Spravato, ketamine, and even psychedelics.
How It Works
- Conventional psychiatry: Indirectly alters brain chemistry through the use of medications
- Interventional psychiatry: Treatments either directly influence brain circuits (like TMS) or act on brain chemistry in new ways (like Spravato)
Treatment Process
- Conventional psychiatry: Often involves trial-and-error with medications
- Interventional psychiatry: Offers more targeted options when medications don’t work
Results
- Conventional psychiatry: Can take weeks to months for improvement
- Interventional psychiatry: May bring faster or more robust relief within days to weeks or even hours
Interventional psychiatry doesn’t replace conventional care. Rather, it expands it by giving patients and providers more choices.
What conditions does interventional psychiatry treat?
Traditionally used for treatment-resistant depression, treatments like TMS and Spravato are also being used to treat a growing range of other conditions:
Treatment-resistant depression (TRD) TMS, Spravato, and ketamine all offer new ways of treating this condition. Spravato is FDA-approved specifically for TRD, while ketamine and TMS have shown strong benefits in clinical practice.
Major depressive disorder with suicidal ideation Spravato is FDA-approved to rapidly reduce suicidal thoughts in patients with severe depression by boosting communication between brain cells. Ketamine is also used off-label in urgent cases to quickly stabilize mood and reduce suicidal intensity.
Post-traumatic stress disorder (PTSD) TMS can also be used off-label to reduce hyperarousal symptoms common in PTSD. Spravato, ketamine, and ketamine-assisted psychotherapy can help patients revisit traumatic memories with less emotional overwhelm, making it easier to process and heal.
Anxiety disorders TMS and ketamine are both being used to help calm brain networks that are stuck in a state of hyperarousal. Ketamine-assisted psychotherapy may also help patients address deep-rooted fears and emotional triggers that drive anxiety.
Obsessive-compulsive disorder (OCD) TMS is FDA-cleared for OCD and uses targeted protocols to disrupt the repetitive brain circuits that drive obsessive thoughts and compulsive behaviors.
ADHD TMS is being explored for its ability to stimulate underactive brain regions responsible for focus and self-control.
Smoking cessation While only one specific TMS coil is FDA-cleared for smoking cessation, other coils are showing promise as an off-label option to help retrain the brain’s reward pathways that drive nicotine cravings.
Addiction and substance use disorders TMS is being studied as a way to reduce alcohol and drug cravings by modulating reward pathways in the brain. Ketamine and ketamine-assisted psychotherapy may also help patients by reducing the intensity of cravings and supporting deeper progress in recovery.
Traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE) TMS is being studied as a way to re-activate underperforming brain regions after injury, which may improve mood, cognition, and executive function.
Available and emerging interventional psychiatry treatments
Since they first emerged in the 1930s, interventional psychiatry treatments have been gaining more attention and research, with a range of innovative treatments that continue to grow:
Current treatments:
- TMS: A non-invasive therapy cleared by the US Food and Drug Administration (FDA) that uses magnetic pulses to stimulate areas of the brain linked to mood regulation
- Electroconvulsive Therapy (ECT): One of the oldest interventional treatments, ECT is still used for severe, treatment-resistant depression and other conditions.
- Ketamine: An anesthetic medication that enhances brain plasticity and reconnects neural pathways involved in mood and cognition
- Spravato: Closely related to ketamine, this FDA-approved nasal spray targets the brain’s glutamate system to restore healthy communication between nerve cells.
- Ketamine-assisted psychotherapy: A guided therapeutic experience using Spravato to help patients access deeper emotional insights and healing
Emerging treatments:
- Psychedelic-assisted therapies: Currently in advanced clinical trials, treatments like psilocybin and MDMA show promise for depression, PTSD, and other conditions.
- Accelerated TMS Protocols The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) program condenses six weeks of treatment into as little as one day.
- Neuroimaging-guided TMS: Using brain scans to personalize where TMS targets specific neural circuits, improving precision and effectiveness.
- AI-driven personalization: Applying artificial intelligence to predict who will respond best to which interventional treatment and tailoring protocols to each patient.
Do interventional psychiatry treatments really work?
The results associated with interventional psychiatry treatments are promising, with more research unlocking even more potential.
Spravato patients in one study reported reduced symptoms of depression, with results lasting up to 4.5 years, especially when combined with ongoing intermittent treatments. Many also report improvements with sleep, concentration, and overall well-being and daily functioning.
In one TMS study, 58% of patients experienced significant improvement of their depression symptoms, with 37% experiencing complete remission.
Together, these results show that interventional psychiatry is opening new doors for people who have struggled to find relief through conventional care alone.
Key takeaways
- Interventional psychiatry expands beyond depression, offering innovative treatments for conditions like PTSD, OCD, ADHD, addiction, smoking cessation, and brain injury–related symptoms.
- TMS, Spravato (esketamine), ketamine, and ketamine-assisted psychotherapy are core interventional psychiatry treatments that each target the brain in unique ways.
- Several interventional treatments are FDA-approved while others are used off-label with growing clinical evidence.
- Research shows promising outcomes, including lasting reductions in depression symptoms and improved daily functioning for many patients.
- The future of interventional psychiatry includes accelerated TMS, neuroimaging for precise targeting, and AI-driven personalization, pointing toward even more effective and individualized care.
Looking for mental health care services near you?
Pacific Mind Health offers medication management, therapy, and interventional treatments like transcranial magnetic stimulation (TMS) and ketamine and Spravato (esketamine). Our experienced clinicians provide compassionate, evidence-based care to help you feel better.
Ready to take the next step? Schedule a free consultation and start your mental health journey today.
